Product ID:EPINEPHRINE INJECTION
MSDS Date:10/07/1992
FSC:6505
NIIN:01-238-5634
MSDS Number: BQWPD

FUJISAWA USA, INC., FUJISAWA PHARMACEUTICAL CO

3 PARKWAY NORTH
DEERFIELD, IL 60015-2548
US

Emergency Phone: 800-888-7704

Info Phone: 708-317-0800

Cage: 0K706

FUJISAWA USA, INC.

DEERFIELD, IL 60015-2548 US

Telephone: 708-317-0800 OR 800-888-7704

Cage: 0K706

EPINEPHRINE (SARA III)

CAS: 51-43-4

RTECS: DO2625000

Fraction By Weight: 0.01%

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS

SODIUM CHLORIDE

CAS: 7647-14-5

RTECS: VZ4725000

Fraction By Weight: 0.816%

SODIUM METABISULFITE

CAS: 7681-57-4

RTECS: UX8225000

Fraction By Weight: 0.05%

OSHA PEL 5 MG/M3

ACGIH TLV: 5 MG/M3; 9293

WATER

CAS: 7732-18-5

RTECS: ZC0110000

PH ADJUSTED WITH CITIRIC ACID AND SODIUM CITRATE.

RTECS: 9999999ZZ

LD50 LC50 Mixture:LD50 (ORAL, RAT) IS UNKNOWN.
Routes of Entry: Inhalation:NO Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE- THIS PRODUCT IS INTENDED FOR
THERAPEUTIC USE ONLY WHEN PRESCRIBED BY A PHYSICIAN. POTENTIAL
ADVERSE REACTIONS FROM PRESCRIBED DOSES AND OVERDOSES ARE
PRESCRIBED IN THE PACKAGE INSERT. OCCUPATIO NAL EXPOSURE HAS NOT
BEEN FULLY INVESTIGATED. CHRONIC- NOT KNOWN
Effects of Overexposure:EYE, SKIN AND RESPIRATORY TRACT IRRITATION
Medical Cond Aggravated by Exposure:PRE-EXISTING SKIN DISORDERS MAY BE
MORE SUSCEPTIBLE TO THIS MATERIAL.

First Aid:CONSULT PHYSICIAN IF SYMPTOMS PERSIST. EYE/SKIN:FLUSH WITH
WATER FOR 15 MINUTES. HOLD EYELIDS OPEN. INHALATION:REMOVE TO FRESH
AIR. PROVIDE CPR/OXYGEN IF NEEDED. INGESTION:FLUSH MOUTH OUT WITH
WATER I MMEDIATELY. SEEK MEDICAL ATTENTION.

Flash Point Method:CC
Flash Point:>200F,>93C
Extinguishing Media:WATER FOG, CARBON DIOXIDE, FOAM OR DRY CHEMICAL.
WATER SPRAY MAY BE USED TO KEEP FIRE EXPOSED CONTAINERS COOL.
Fire Fighting Procedures:WEAR PROTECTIVE CLOTHING AND NIOSH-APPROVED
SELF-CONTAINED BREATHING APPARATUS.
Unusual Fire/Explosion Hazard:MAY EMIT TOXIC FUMES OF NOX.

Spill Release Procedures:WEAR PROTECTIVE EQUIPMENT. USE ABSORBENT
TOWELS OR BOOMS TO CLEAN-UP SPILL. WIPE SURFACES CLEAN AND WASH
WITH SOAP AND WATER.
Neutralizing Agent:WEAK BASE

Handling and Storage Precautions:AS A GENERAL RULE, WHEN HANDLING
PHARMACEUTICAL PRODUCTS, AVOID ALL CONTACT AND INHALATION OF DUST,
FUME, MISTS AND/OR VAPORS ASSOCIATED WITH PRODUCT.
Other Precautions:KEEP OUT OF REACH OF CHILDREN.

Respiratory Protection:WITH SATISFACTORY VENTILATION, RESPIRATORY
PROTECTION NOT USUALLY REQUIRED.
Ventilation:MECHANICAL (GENERAL) ROOM VENTILATION IS USUALLY
SATISFACTORY. USE LOCAL EXHAUST VENTILATION WHEN NECESSARY.
Protective Gloves:DISPOSABLE LATEX RECOMMENDED
Eye Protection:SAFETY GOGGLES/GLASSES RECOMMENDED
Other Protective Equipment:EYE WASH STATION, DISPOSABLE GARMENTS IF
DIRECT CONTACT IS ANTICIPATED.
Work Hygienic Practices:PRACTICE GOOD HYGIENIC PROCEDURE.
Supplemental Safety and Health
FLASH POINT IS ESTIMATED.

HCC:C3
Boiling Pt:B.P. Text:NOT KNOWN
Melt/Freeze Pt:M.P/F.P Text:NOT KNOWN
Vapor Pres:NOT KNOWN
Vapor Density:6.31
Spec Gravity:NOT KNOWN
pH:2.2-5
Evaporation Rate & Reference:NOT KNOWN
Solubility in Water:SLIGHTLY SOLUBLE
Appearance and Odor:CLEAR, COLORLESS, ODORLESS SOLUTION

Stability Indicator/Materials to Avoid:YES
STRONG BASES
Stability Condition to Avoid:EXPOSURE TO LIGHT MAY CAUSE DECOMPOSITION.
Hazardous Decomposition Products:MAY EMIT TOXIC FUMES OF NOX.

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH ALL LOCAL, STATE
AND FEDERAL REGULATIONS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.